Tissium
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
74 Rue Du Faubourg Saint-antoine, Paris,...Phone Number
+33 176217228Website
www.tissium.comRevenue
$24.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Tissium
TISSIUM is a privately-owned medtech company that is dedicated to the rapid development and commercialization of a unique biopolymer platform to address various unmet clinical needs. The company was founded in 2013 and is headquartered in Paris, France.Explore more
Tissium Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tissium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Tissium recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Tissium had a recent Job posting/layoffs
Check out if Tissium is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Tissium
Check if Tissium has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Tissium has new funding data
Product Launch: Get notified when Tissium launches new products
Tissium, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Tissium as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Tissium is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tissium is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tissium.
Tissium financials insights
Gather financial insights about Tissium, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$27.4M
2020
Series B
$42.8M
Debt
$8.2M
2021
Series C
$59.1M
2023
Series D
$53.8M
2026
Other Financing Round
$68.1M
Tissium Tech Stack
A closer look at the technologies used by Tissium
See more technologies
Most Recent Scoops
Funding
Funding
Open Position
Open Position
Open Position
Open Position
Tissium News & Media
Tissium secures up to $68M to back rollout of nerve repair platform
The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.TISSIUM secures €60 million to support commercial and clinical activities and platform expansion
Paris, France, Cambridge, USA, June 24, 2026 – TISSIUM, a medical technology company pioneering biomorphic programmable polymers for tissue reconstruction, today announced a €60 million financing package combining a completed €30 million Series D2 financing with a €30 million financing facility from the European Investment Bank (EIB).TISSIUM Selected to the French Tech Next40 Program
Paris, France, June 15, 2026 – TISSIUM, a medical technology company pioneering biomorphic programmable polymers for tissue reconstruction, today announced its selection to the French Tech Next40 Class of 2026.TISSIUM APPOINTS MARC QUARTULLI AS VICE PRESIDENT OF CLINICAL AFFAIRS
Paris, France, Cambridge, USA, May 5th, 2026 – TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Marc Quartulli as its Vice President of Clinical Affairs.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tissium
Sign Up For FreeTo access detailed company insights
TISSIUM is a privately-owned medtech company that is dedicated to the rapid development and commercialization of a unique biopolymer platform to address various unmet clinical needs. The company was founded in 2013 and is headquartered in Paris, France.... Read More
